Lobe Sciences Ltd.
LOBE
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 71.84% | -559.90% | 29.33% | -6.54% | 59.70% |
| Total Depreciation and Amortization | -- | -100.00% | -1.43% | 1.45% | 11.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.95% | 2,052.53% | -298.33% | -5.52% | -64.82% |
| Change in Net Operating Assets | -9.83% | 33.27% | -56.92% | 27.54% | -31.34% |
| Cash from Operations | -1,599.04% | 95.60% | -914.16% | 66.43% | 85.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -33.19% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -33.52% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 1,073.91% | -136.51% | 182.89% | -1,050.00% | 366.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -201.45% | 745.00% | 158.25% | 54.96% | 85.13% |